FDA Advisers Bullish on RSV Shots for Kids, Even as Safety Signals Shut Down Moderna Trials
Vaccine makers are developing 26 different RSV vaccines or monoclonal antibodies for all age groups, as they vie for a slice of the rapidly expanding market. Discussions during Thursday’s FDA vaccine advisory committee focused on the “unmet need” for more RSV shots for infants and toddlers and how to move them forward.
Discuss on Nostr!
Nostr Note ID note138727lgr4nq0lh5cdfvvxrft4n5gavqa6h3kk5gewmf9r8rw4mxsdlrhm9 Open on Primal.net Open on Snort.social Open on Iris.to Open on Coracle.social
New to Nostr?
Create an account now & join the conversation!
Promote it on DissentWatch!
- To advertise this post for $0.02 per visit send bitcoins to the address below
- The post will be promoted daily via social media & our "Featured News" display in multiple places
- You can add more anytime
- Ranking order in the Featured News box is based on the balance remaining
Received: 0 mBTC (0.00 USD)
Spent: 0 mBTC (0.00 USD)
Balance: 0 mBTC (0.00 USD)
The amounts above may be lagging behind. If you just sent a payment click below to get more up to date results and push the post to the "Featured News" box faster.